共 26 条
- [21] Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2024, 7 (03) : 238 - 245
- [22] Can symptoms predict esophageal motor function or acid exposure in gastroesophageal reflux disease? - A comparison of esophageal manometric and twenty-four-hour pH parameters in typical and extraesophageal gastroesophageal reflux disease JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (02) : 128 - 132
- [26] The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications Digestive Diseases and Sciences, 2005, 50 : 1909 - 1915